Skip to main content
Home
  • Twitter
  • Facebook
  • YouTube
  • Instagram
  • Blog
  • Contact
  • de
animals Animals
climate Climate Crisis
Conflict Regions
Culture
Democracy
Development & Aid
Economy
Education
energy Energy
environment Environment
Exemplary People
food Food & Agriculture
Globalization
Health
Human Rights
Men
military Military
nature Nature
News Media
nuclear weapons Nuclear Disarmament
Peace
Politics
Religions
Social Justice
Sustainability
Women
Youth
Useful Tools
Real News
Events

SARS-CoV-2 - the virus

  1. Home
  2. Health
  3. Info by Disease
  4. Infections
  5. Novel Coronavirus Guide
  6. Scientific Papers
Suggest a link
Cancel
  • Study mapping how SARS-CoV-2 disrupts mitochondria suggests a cause for long Covid - Stat News 09.08.23375901
  • Quantifying transmission risk of SARS-CoV-2 in different situations - BMJ 20.01.22271564
  • Covid loses 90% of ability to infect within five minutes in air – study - Guardian 11.01.22269130
  • Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy? - Nature 26.11.21263693
  • Covid-19: Why China is sticking to “zero tolerance” public health measures - BMJ 25.11.21263772
  • Covid-19: Fatal errors, not fatalism, created UK’s public health disaster - BMJ 14.10.21259490
  • Airborne transmission of respiratory viruses - Science 27.08.21256120
  • Two more coronaviruses may infect people - Science 28.05.21246275
  • Estimating infectiousness throughout SARS-CoV-2 infection course - Science 25.05.21245946
  • Just 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in communities - PNAS 25.05.21245816
  • SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans - nature 24.05.21245739
  • Reaching the theoretical herd immunity threshold in Iquitos, Peru: are seroprevalence data enough? - Lancet 19.05.21245625
  • Report: Making COVID-19 the last pandemic, Independent Panel for Pandemic Preparedness and Response - Lancet 12.05.21255031
  • SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties - Lancet 28.04.21247546
  • Correlation of national and healthcare workers COVID-19 infection data; implications for large-scale viral testing programs - PLOS ONE 23.04.21251461
  • Laboratory Modeling of SARS-CoV-2 Exposure Reduction Through Physically Distanced Seating in Aircraft Cabins Using Bacteriophage Aerosol - CDC 14.04.21247517
  • “In an ocean of ashes, islands of order”: WHO's SARS-CoV-2 origin report - Lancet 09.04.21247547
  • Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population - JAMA 05.04.21251497
  • SARS-CoV-2 infection of the oral cavity and saliva - nature medicine 25.03.21247549
  • Covid-19 and aerosol transmission: up in the air - BMJ 05.03.21247518
  • Emergency Manager’s Weekly Report Coronavirus Pandemic Situation Report #69 - 25.01.21247539
  • Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study - Lancet 18.01.21247568
  • Past COVID-19 infection provides some immunity but people may still carry and transmit virus - Gov.Uk 14.01.21247540
  • Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections - Lancet 18.12.20247551
  • Immunological memory to SARS-CoV-2 assessed for greater than six months after infection - biorxiv 15.11.20247550
  • Sex differences in the decline of neutralizing antibodies to SARS-CoV-2 - medRxiv 15.11.20247555
  • SARS-CoV-2 Transmission among Marine Recruits during Quarantine - nejm 11.11.20268440
  • Preexisting and de novo humoral immunity to SARS-CoV-2 in humans - Science 06.11.20247554
  • Robust neutralizing antibodies to SARS-CoV-2 infection persist for months - Science 28.10.20247556
  • SARS‐CoV‐2 outbreak investigation in a German meat processing plant - EmboPress 27.10.20268443
  • Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks — MMWR 18.09.20247525
  • Association Between CMS Quality Ratings and COVID-19 Outbreaks in Nursing Homes - MMWR 18.09.20268448
  • SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19 - Cancer Cell 15.09.20247557
  • Coronavirus reinfections: three questions scientists are asking - nature 04.09.20247524
  • SARS-CoV-2 Infection of Airway Cells - NEJM 03.09.20247559
  • Humoral Immune Response to SARS-CoV-2 in Iceland - NEMJ 01.09.20247560
  • The coronavirus is most deadly if you are older and male — new data reveal the risks - Nature 28.08.20247542
  • Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women - Jama Network 22.08.20247558
  • Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea - …247561
  • Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans - Science 04.08.20247562
  • Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care - nature 29.07.20247519
  • Particle sizes of infectious aerosols: implications for infection control - Lancet 24.07.20247520
  • Investigation of a superspreading event preceding the largest meat processing plant-related SARS-Coronavirus 2 outbreak in Germany - SSRN 23.07.20247523
  • Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections - Nature 18.06.20247552
  • Reducing transmission of SARS-CoV-2 - Science 27.05.20247564
  • How do children spread the coronavirus? The science still isn’t clear - nature 07.05.20247522
  • Coronavirus is spreading under the radar in US homeless shelters - Nature 07.05.20247541
  • Early Release - Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19 - CDC 05.05.20247563
  • COVID-19 Antibody Seroprevalence in Santa Clara County, California - medRxiv 30.04.20268513
  • * Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor - Nature 20.04.20247566
  • Will antibody tests for the coronavirus really change everything? - Nature Medicine 18.04.20247526
  • How does coronavirus kill? Clinicians trace a ferocious rampage through the body - Science Mag 17.04.20247529
  • * Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic - National Academies 01.04.20247521
  • Roadblocks to Infection Prevention Efforts in Health Care: SARS-CoV-2/COVID-19 Response - Cambridge Core 30.03.20268526
  • Coronavirus latest: pandemic could have killed 40 million without any action - Nature 27.03.20247527
  • A mathematical model for the spatiotemporal epidemic spreading of COVID19 -Medrxiv 23.03.20268522
  • The coronavirus did not escape from a lab. Here's how we know - Live Science 21.03.20247532
  • A Model Describing COVID-19 Community Transmission Taking into Account Asymptomatic Carriers and Risk Mitigation - MedRxiv 18.03.20268524
  • Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) - Science 16.03.20247545
  • * Temporal dynamics in viral shedding and transmissibility of COVID-19 - Gabriel M Leung, medRxiv 15.03.20268535
  • Reinfection could not occur in SARS-CoV-2 infected rhesus macaques - bioRxiv 13.03.20247567
  • Why does the coronavirus spread so easily between people? - Nature 11.03.20247530
  • SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - NCBI 04.03.20247565
  • Molecular immune pathogenesis and diagnosis of COVID-19 - Journal of Pharmaceutical Analysis 03.03.20268531
  • Laboratory Readiness and Response for Novel Coronavirus (2019-nCoV) in Expert Laboratories in 30 EU/EEA Countries, January 2020 - Euro Surveill 13.02.20247533
  • Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents - Journal of Hospital Infection 06.02.20247535
  • Pathogenicity and Transmissibility of 2019-nCoV—A Quick Overview and Comparison with Other Emerging Viruses - Microbes & Infection 04.02.20247536
  • 'It’s a Moral Imperative:' Archivists Made a Directory of 5,000 Coronavirus Studies to Bypass Paywalls - Vice 03.02.20247543
  • Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019 - CDC 2/20247553
  • Mining coronavirus genomes for clues to the outbreak’s origins - Science 31.01.20247537
  • Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak - Wellcome 31.01.20247544
  • A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment - NEJM 24.01.20247531
  • Commentary: Return of the Coronavirus: 2019-nCoV - Viruses 24.01.20 (open access)247538
  • Coronavirus Infections—More Than Just the Common Cold - JAMA 23.01.20247528
  • * Detection of 2019 Novel Coronavirus (2019-nCoV) by Real-Time RT-PCR - Corman VM et al, Euro Surveill 23.01.20247534
  • Real-time Assessment of Community Transmission findings - Imperial College London247569
  • About Us
    • FAQ
    • Endorsements
    • Privacy Policy
    • Disclaimer
    • Publisher
    • Press
  • Get Involved
    • What can I do?
    • Add a Link
    • Share knowledge
    • Donate
    • Contact us

Follow us

  • Twitter
  • Facebook
  • YouTube
  • Instagram
to top

share

Privacy
Details
Imprint | Privacy
Your selection from
The controller (Dr. Norbert Stute, Austria) would like to use the following services in order to process your personal data. Technologies such as cookies, localStorage, etc. can be used for personalization. This is not necessary for the use of the website, but allows us to interact with you more closely. If you wish, you can adjust or revoke your consent at any time via our privacy policy.
Other content (1 Service)
Integration of additional information
Switch to accept or reject the category Other content

X (Twitter)
Twitter International Unlimited Company, Ireland
All Detailsto X (Twitter)
All Detailsto X (Twitter)
Switch to accept or reject the service X (Twitter)
When accessing some sub-services of our website, additional personal services are processed. Processed data categories: technical connection data of the server access (IP address, date, time, requested page, browser information)data about the use of the website and the logging of clicks on individual elements. Purpose of processing: Selection of online advertising on other platforms, which are automatically selected using real-time bidding based on user behavior and provision of social media services. The legal basis for processing: Your consent according to Art. 6 (1) a GDPR. Data is transmitted: as joint controllers for Twitter International Unlimited Company, One Cumberland Place, Fenian Street Dublin 2, D02 AX07, Ireland. This may also mean a transfer of personal data to a country outside the European Union. The data is transmitted on the basis of your consent in accordance with Art. 6 Para. 1 lit a in conjunction with Art. 49 Para. 1 lit a GDPR. You were informed before you gave your consent that the USA does not have a level of data protection that corresponds to the standards of the EU. In particular, US secret services can access your data without you being informed and without you being able to take legal action against it.
Switch to accept or reject the service